Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Applicability of Biomarkers Is Far-Reaching
Cancer Detection, Assay Development, Early Drug Development, and Diagnostics Top List
- The latest techniques used to advance biomarker research were among the topics discussed at CHI’s “Biomarker World Congress” held in Philadelphia recently. Several of the presenters at the meeting spoke to GEN about their work using biomarkers for cancer detection, assay development, early drug development, clinical development, and diagnostics. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.